{
    "clinical_study": {
        "@rank": "139522", 
        "arm_group": [
            {
                "arm_group_label": "Test arm", 
                "arm_group_type": "Experimental", 
                "description": "ALS-L1023 300mg in two tablets"
            }, 
            {
                "arm_group_label": "Comparator arm", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo in two tablets"
            }
        ], 
        "brief_summary": {
            "textblock": "The main objective of this study is to evaluate efficacy and safety of ALS-L1023 tablet in\n      patients with abdominal obesity of metabolic syndrome."
        }, 
        "brief_title": "Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Abdominal Obesity Metabolic Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Obesity, Abdominal", 
                "Metabolic Syndrome X"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged between 20 and 64 years(Both genders)\n\n          -  more than 2 among components of the metabolic syndrome\n\n               -  Triglyceride >= 150mg/dL\n\n               -  HDL-D: Women < 50mg/dL or Men < 40mg/dL\n\n               -  Hypertension: Systolic blood pressure >= 130mmHg or Diastolic blood pressure >=\n                  85mmHg\n\n               -  Hyperglycemia: fasting plasma glucose >= 100 mg/dL\n\n          -  Informed consent awarding\n\n        Exclusion Criteria:\n\n          -  Alcohol or any drug abuse\n\n          -  Any investigational medication during the preceding 3 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "64 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01872182", 
            "org_study_id": "HM-MELS-301"
        }, 
        "intervention": [
            {
                "arm_group_label": "Test arm", 
                "description": "daily twice for 12 weeks", 
                "intervention_name": "ALS-L1023", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Comparator arm", 
                "description": "daily twice for 12 weeks", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 7, 2014", 
        "location": {
            "contact": {
                "email": "hyesoon@amc.seoul.kr", 
                "last_name": "Hye Soon Park, M.D., Ph.D., M.P.H."
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "5 Institutions"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Double-Blind, Placebo Controlled, Multicenter, 12-week Phase 3 Study to Evaluate Efficacy and Safety of ALS-L1023 Tablet in Patients With Abdominal Obesity of Metabolic Syndrome", 
        "overall_contact": {
            "email": "inseungshin@hanmi.co.kr", 
            "last_name": "Inseung Shin"
        }, 
        "overall_official": {
            "affiliation": "Asan Medical Center", 
            "last_name": "Hye Soon Park, M.D., Ph.D., M.P.H.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Percent change from baseline to 12 week in visceral fat area measured by CT", 
            "safety_issue": "No", 
            "time_frame": "baseline and 12 week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01872182"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "improvement of metabolic profile", 
                "safety_issue": "No", 
                "time_frame": "baseline and 12 week"
            }, 
            {
                "measure": "change of insulin resistance", 
                "safety_issue": "No", 
                "time_frame": "baseline and 12 week"
            }, 
            {
                "measure": "change of BMI", 
                "safety_issue": "No", 
                "time_frame": "baseline and 12 week"
            }
        ], 
        "source": "Hanmi Pharmaceutical Company Limited", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hanmi Pharmaceutical Company Limited", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}